Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
| Report ID | 131827 |
| Drug Identification Number | 02303086 |
| Brand name | HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) |
| Common or Proper name | HEPARIN SODIUM INJECTION USP (MULTIDOE VIAL-WITH PRESERVATIVE) |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM |
| Strength(s) | 1000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10ML 10LIVI CA |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-15 |
| Estimated end date | 2021-01-29 |
| Actual end date | 2021-01-29 |
| Shortage status | Resolved |
| Updated date | 2021-02-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-02-01 | French | Compare |
| v3 | 2021-02-01 | English | Compare |
| v2 | 2021-01-18 | French | Compare |
| v1 | 2021-01-18 | English | Compare |
Showing 1 to 4 of 4